Prion strain-dependent tropism is maintained between spleen and granuloma and relies on lymphofollicular structures.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
10 10 2019
Historique:
received: 27 12 2018
accepted: 18 09 2019
entrez: 12 10 2019
pubmed: 12 10 2019
medline: 11 11 2020
Statut: epublish

Résumé

In peripherally acquired prion diseases, prions move through several tissues of the infected host, notably in the lymphoid tissue, long before the occurrence of neuroinvasion. Accumulation can even be restricted to the lymphoid tissue without neuroinvasion and clinical disease. Several experimental observations indicated that the presence of differentiated follicular dendritic cells (FDCs) in the lymphoid structures and the strain type are critical determinants of prion extraneural replication. In this context, the report that granulomatous structures apparently devoid of FDCs could support prion replication raised the question of the requirements for prion lymphotropism. The report also raised the possibility that nonlymphoid tissue-tropic prions could actually target these inflammatory structures. To investigate these issues, we examined the capacity of closely related prions, albeit with opposite lymphotropism (or FDC dependency), for establishment in experimentally-induced granuloma in ovine PrP transgenic mice. We found a positive correlation between the prion capacity to accumulate in the lymphoid tissue and granuloma, regardless of the prion detection method used. Surprisingly, we also revealed that the accumulation of prions in granulomas involved lymphoid-like structures associated with the granulomas and containing cells that stain positive for PrP, Mfge-8 but not CD45 that strongly suggest FDCs. These results suggest that the FDC requirement for prion replication in lymphoid/inflammatory tissues may be strain-dependent.

Identifiants

pubmed: 31601984
doi: 10.1038/s41598-019-51084-1
pii: 10.1038/s41598-019-51084-1
pmc: PMC6787085
doi:

Substances chimiques

Antigens, Surface 0
Mfge8 protein, mouse 0
Milk Proteins 0
Prion Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

14656

Références

J Gen Virol. 2000 Dec;81(Pt 12):3115-3126
pubmed: 11086143
J Neurosci. 2007 Jun 27;27(26):6965-71
pubmed: 17596445
J Virol. 2001 Jul;75(13):5977-84
pubmed: 11390599
Eur J Biochem. 2000 May;267(10):2833-9
pubmed: 10806380
Protein Sci. 2001 Apr;10(4):854-63
pubmed: 11274476
PLoS One. 2013 May 03;8(5):e62830
pubmed: 23658779
Trends Immunol. 2012 Jun;33(6):297-305
pubmed: 22622061
J Biol Chem. 2005 Mar 25;280(12):11247-58
pubmed: 15618225
Immunology. 2013 Mar;138(3):246-57
pubmed: 23121447
Nat Med. 1999 Nov;5(11):1308-12
pubmed: 10545999
Nat Rev Immunol. 2009 Sep;9(9):618-29
pubmed: 19644499
J Pathol. 2000 Mar;190(4):495-502
pubmed: 10700001
J Pathol. 1992 Dec;168(4):413-8
pubmed: 1362440
PLoS Pathog. 2010 Dec 02;6(12):e1001217
pubmed: 21152012
BMJ. 2013 Oct 15;347:f5675
pubmed: 24129059
Eur J Immunol. 2002 Jul;32(7):1888-96
pubmed: 12115608
Pathogens. 2018 Jan 01;7(1):
pubmed: 29301257
Science. 2012 Jan 27;335(6067):472-5
pubmed: 22282814
Nature. 1992 Apr 16;356(6370):577-82
pubmed: 1373228
J Virol. 1991 Nov;65(11):6292-5
pubmed: 1681118
PLoS Pathog. 2017 Mar 29;13(3):e1006298
pubmed: 28355274
Science. 2000 May 19;288(5469):1257-9
pubmed: 10818004
Proc Natl Acad Sci U S A. 1998 Nov 10;95(23):13363-83
pubmed: 9811807
Vet Res. 2016 Sep 15;47(1):88
pubmed: 27641251
PLoS Pathog. 2011 Dec;7(12):e1002402
pubmed: 22144895
Scand J Immunol. 1986 Sep;24(3):327-34
pubmed: 3749816
Arch Virol Suppl. 2000;(16):23-38
pubmed: 11214927
Virus Res. 1989 Mar;12(3):201-11
pubmed: 2499134
PLoS Pathog. 2015 Jun 18;11(6):e1004983
pubmed: 26086786
Immunol Today. 1998 May;19(5):201-3
pubmed: 9613034
J Virol. 2000 Jun;74(12):5432-40
pubmed: 10823847
Nat Med. 2000 Jul;6(7):719-20
pubmed: 10888894
Am J Pathol. 2006 Mar;168(3):927-35
pubmed: 16507908
Nature. 1996 Oct 24;383(6602):685-90
pubmed: 8878476
Neurobiol Dis. 2011 Jan;41(1):219-25
pubmed: 20875860
Proc Natl Acad Sci U S A. 2002 Jan 22;99(2):919-24
pubmed: 11792852
Immunology. 2005 Feb;114(2):225-34
pubmed: 15667567
mBio. 2013 Dec 31;5(1):e00829-13
pubmed: 24381300
Immunology. 2011 Aug;133(4):482-98
pubmed: 21635249
PLoS Pathog. 2010 Apr 15;6(4):e1000859
pubmed: 20419156
Immunity. 2008 Dec 19;29(6):998-1008
pubmed: 19100703
J Virol. 2005 Sep;79(18):11858-63
pubmed: 16140762
J Virol. 2003 Jun;77(12):6845-54
pubmed: 12768004
Science. 2005 Feb 18;307(5712):1107-10
pubmed: 15661974

Auteurs

Iman Al-Dybiat (I)

VIM, INRA, Université Paris-Saclay, 78350, Jouy-en-Josas, France.

Mohammed Moudjou (M)

VIM, INRA, Université Paris-Saclay, 78350, Jouy-en-Josas, France.

Davy Martin (D)

VIM, INRA, Université Paris-Saclay, 78350, Jouy-en-Josas, France.

Fabienne Reine (F)

VIM, INRA, Université Paris-Saclay, 78350, Jouy-en-Josas, France.

Laetitia Herzog (L)

VIM, INRA, Université Paris-Saclay, 78350, Jouy-en-Josas, France.

Sandrine Truchet (S)

VIM, INRA, Université Paris-Saclay, 78350, Jouy-en-Josas, France.

Patricia Berthon (P)

UMR Infectiologie et Santé Publique, 37380, Nouzilly, France.

Hubert Laude (H)

VIM, INRA, Université Paris-Saclay, 78350, Jouy-en-Josas, France.

Human Rezaei (H)

VIM, INRA, Université Paris-Saclay, 78350, Jouy-en-Josas, France.

Olivier Andréoletti (O)

UMR INRA ENVT 1225, Interactions Hôtes Agents Pathogènes, Ecole Nationale Vétérinaire de Toulouse, 23 Chemin des Capelles, 31076, Toulouse, France.

Vincent Béringue (V)

VIM, INRA, Université Paris-Saclay, 78350, Jouy-en-Josas, France. vincent.beringue@inra.fr.

Pierre Sibille (P)

VIM, INRA, Université Paris-Saclay, 78350, Jouy-en-Josas, France. pierre.sibille@inra.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH